A Case of Muscle Invasive Bladder Cancer Treated With Systemic Chemotherapy During Pregnancy

Stephen R Kennedy, Qurrat Mahmood, Ananya Choudhury, Jacqueline E Livsey


Bladder cancer during pregnancy is rare and there are no previous reports of the use combination chemotherapy being administered for muscle invasive bladder cancer (MIBC) during pregnancy. We report a case of muscle invasive bladder cancer diagnosed during pregnancy and treated during the second and third trimester with 2 cycles of systemic chemotherapy using Carboplatin and Adriamycin. We considered this novel combination regime to have activity against bladder cancer, but be safer in pregnancy than the standard regimes. After receiving chemotherapy, the neonate was delivered at 32 weeks by caesarean section and suffered no ill effects from the chemotherapy. The infant continues to develop normally. The patient went on to receive radical bladder radiotherapy.



Pregnancy; Bladder cancer; Chemotherapy 

Full Text: HTML PDF

Browse  Journals  


Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics






Journal of Clinical Gynecology & Obstetrics, quarterly, ISSN 1927-1271 (print), 1927-128X (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal, the authors retain the copyright, the journal is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International
License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)

This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jcgo.org   editorial contact: editor@jcgo.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.

Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.